rs104894721
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1_ModeratePM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000660.7(TGFB1):c.652C>T(p.Arg218Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000069 in 1,449,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R218H) has been classified as Pathogenic.
Frequency
Consequence
NM_000660.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGFB1 | NM_000660.7 | c.652C>T | p.Arg218Cys | missense_variant | 4/7 | ENST00000221930.6 | |
TGFB1 | XM_011527242.3 | c.652C>T | p.Arg218Cys | missense_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGFB1 | ENST00000221930.6 | c.652C>T | p.Arg218Cys | missense_variant | 4/7 | 1 | NM_000660.7 | P1 | |
TGFB1 | ENST00000597453.1 | n.183C>T | non_coding_transcript_exon_variant | 3/3 | 1 | ||||
TGFB1 | ENST00000600196.2 | c.652C>T | p.Arg218Cys | missense_variant | 4/6 | 5 | |||
TGFB1 | ENST00000677934.1 | c.634+2517C>T | intron_variant |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449608Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 720222
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Diaphyseal dysplasia Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 15, 2004 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | TGFB1: PS2, PM2, PM5, PP1, PP4, PS3:Supporting, PS4:Supporting, BP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 07, 2021 | Reported previously as the most frequently identified variant among families with Camurati-Engelmann disease (Kinoshita et al., 2004); Published functional studies demonstrate that this variant disrupts dimerization and reduces the stability of the latent TGF-beta 1 complex (Walton et al., 2010); Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28943142, 15103729, 25099136, 23846138, 10973241, 11062463, 30034812, 29620655, 12843182, 20308061) - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 09, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 218 of the TGFB1 protein (p.Arg218Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant Camurati-Engelmann syndrome (PMID: 10973241, 23846138, 25099136, 30034812). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 12531). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TGFB1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects TGFB1 function (PMID: 19584867). For these reasons, this variant has been classified as Pathogenic. - |
See cases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Personalized Medicine, Children's Hospital Los Angeles | Dec 21, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at